EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Antibody Therapeutics

ISSN 2516-4236 · Oxford University Press (OUP)

Latest articles

  1. Engineering a novel asymmetric head-to-tail (HtT) 1+1 and 2+1 T cell bispecific antibody (TCB) platform with superior T cell killing compared to 1+1 bispecific IgG antibodies

    Omar Abdelmotaleb, Antonio Sorrentino, Christiane Neumann, Tanja Fauti, Tina Weinzierl, Anne Freimoser-Grundschober, Claudia Ferrara Koller, Linda Arnold, Sylvia Herter, Matthias E Lauer, Philippe Ringler, Clara Albani, Simone Lang, Sarah Diggelmann, Florian Limani, Sara Colombetti, Johannes Sam, Erwin Puijenbroek, Ekkehard Moessner, Peter Brünker, Marina Bacac, Pablo Umana, Christian Klein, Inja Waldhauer

    Published: 2026-11-08DOI: 10.1093/abt/tbag057

  2. Profiling the efficacy of CR1 monoclonal antibody series against New World Arenaviruses

    Sharon Jan, Christopher A Sumner, Grecia A Sandoval, Stephen Won, Laura D Weinstock, Anna L Lara, Anupama Sinha, Megan Shelby, Emilia Grzesiak, Andre Goncalves, Mary Silva, Emily Engelhart, Sneha Rangarajan, Melissa C Kerzic, Carter A Mitchell, Elizabeth B Allmon, Yenny Goez-Gazi, John W Dutton, Ricardo Carrion, Thomas Desautels, Kendra J Alfson, Chris M Cirimotich, Dylan M Johnson

    Published: 2026-09-03DOI: 10.1093/abt/tbag046

  3. TROP2 antibody–drug conjugate: unique epitope engagement drives differentiated efficacy

    Hang Chen, Xiaoshan Min, Qingwen Cheng, Lin Liu, Brittany Jiang, Yinan Wu, Juliet G Carbon, Daeun Nam, Jing Zhou, Silvia C Bobeica, Shih-Ping Chen, Jennifer Li, Nikolai Sharkov, Subhadra Dash, Shidong Ma, Sujun Hua, Fang Wang, Andres Rojas, Guorui Zhao, Shenjun Li, Hui Wang, Qinbin Zhang, Jing Tao, Zhan jiao Yu, Lili Wang, Wei Zhang, Yuanhao Li, Jing Jiang, Jianmin Fang, Zhulun Wang

    Published: 2026-06-29DOI: 10.1093/abt/tbag018

Volumes

2026 · 602025 · 282024 · 352023 · 562022 · 302021 · 272020 · 282019 · 142018 · 10

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.